Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid LeukemiaShanshan Pei, Craig T. Jordan, Annika Gustafson et al.|Cancer Discovery|2020Cited by 550
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E. Ramsey, Michael R. Savona|Clinical Cancer Research|2020Cited by 22
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine ModelHaley E. Ramsey, Michael R. Savona|Targeted Oncology|2020Cited by 20
TLR3 agonism augments CD47 inhibition in acute myeloid leukemiaHaley E. Ramsey, Michael R. Savona|Haematologica|2023Cited by 7